Related Experiment Video
Updated: May 10, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
Published on: April 11, 2025
Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression
Delin Chen1, Ning Kon, Jiayun Zhong
1Institute for Cancer Genetics and Department of Pathology and Cell Biology, Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, 1130 St. Nicholas Avenue, New York, NY 10032, USA.
Abstract:
ARF suppresses aberrant cell growth upon c-Myc overexpression by activating p53 responses. Nevertheless, the precise mechanism by which ARF specifically restrains the oncogenic potential of c-Myc without affecting its normal physiological function is not well understood. Here, we show that low levels of c-Myc expression stimulate cell proliferation, whereas high levels inhibit by activating the ARF/p53 response. Although the mRNA levels of ARF are induced in both scenarios, the accumulation of ARF protein occurs only when ULF-mediated degradation of ARF is inhibited by c-Myc overexpression. Moreover, the levels of ARF are reduced through ULF-mediated ubiquitination upon DNA damage. Blocking ARF degradation by c-Myc overexpression dramatically stimulates the apoptotic responses. Our study reveals that ARF stability control is crucial for differentiating normal (low) versus oncogenic (high) levels of c-Myc expression and suggests that differential effects on ULF- mediated ARF ubiquitination by c-Myc levels act as a barrier in oncogene-induced stress responses.
Insights
ARF protein stability, controlled by c-Myc levels, is key to distinguishing normal cell growth from oncogenic overstimulation. This mechanism prevents uncontrolled cell proliferation and promotes apoptosis when needed.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Stress Response
Background:
- ARF (Alternative Reading Frame) protein is known to suppress aberrant cell growth by activating p53 responses, particularly upon c-Myc overexpression.
- The exact mechanism by which ARF restrains c-Myc's oncogenic potential without impacting its normal functions remains unclear.
Purpose of the Study:
- To elucidate the precise mechanism of ARF's regulation by c-Myc.
- To understand how ARF stability differentiates normal versus oncogenic c-Myc levels.
- To investigate the role of ULF-mediated degradation in ARF stability control.
Main Methods:
- Investigated ARF protein accumulation under varying c-Myc expression levels.
- Analyzed ARF mRNA induction and protein stability.
- Examined the impact of c-Myc on ULF-mediated ARF ubiquitination and degradation.
- Assessed apoptotic responses when ARF degradation was blocked.
Main Results:
- Low c-Myc stimulates proliferation; high c-Myc inhibits it by activating the ARF/p53 pathway.
- ARF protein accumulates only when c-Myc overexpression inhibits ULF-mediated degradation.
- DNA damage leads to reduced ARF levels via ULF-mediated ubiquitination.
- Blocking ARF degradation upon c-Myc overexpression significantly enhances apoptosis.
Conclusions:
- ARF protein stability control is critical for distinguishing between normal and oncogenic c-Myc expression levels.
- Differential regulation of ULF-mediated ARF ubiquitination by c-Myc levels acts as a safeguard against oncogene-induced stress.
- This provides insight into cellular barriers against oncogenic transformation.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Induced Pluripotent Stem Cells
Somatic cells are...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

